Sometime in June, the Jordan Brand's Phase 23 Hoops model will drop in an assortment of colorful Candy Pack-like looks. In addition to the standard Varsity Red, Varsity Maize and Pine Green styles, a ...
Acticor Biotech is discontinuing a phase 2/3 study of a blood thinner given alongside heart surgery based on the results of a futility analysis. The French company had been testing the drug, ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Two pharmaceutical firms announced they have started a ...
Thus far, the Jordan Phase 23 Hoops releases we've seen have featured multi-color detailing on the plastic wing supports and solid rubber outsoles. The latest colorway to surface switches it up a bit, ...
NEW HAVEN, Conn.--(BUSINESS WIRE)--Veradermics, Incorporated, a dermatologist-founded, late clinical-stage biopharmaceutical company developing potentially first-in-class therapeutics for common ...
BASKING RIDGE, N.J. & RAHWAY, N.J.--(BUSINESS WIRE)--Daiichi Sankyo (TSE: 4568) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the first patient has ...
DiaMedica Therapeutics (NASDAQ:DMAC) said the US Food and Drug Administration has lifted a hold on its Phase 2/3 clinical trial for its stroke drug candidate DM199 and that it has agreed to a $37.5M ...
SOUTH SAN FRANCISCO, Calif., April 10, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company, today announced plans to issue a joint IDEAYA and Servier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results